Gastrointestinal Neoplasm Clinical Trials in Houston, Texas
7 recruitingHouston, Texas
Showing 1–7 of 7 trials
Recruiting
Phase 3
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Phase 3
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
GlaxoSmithKline450 enrolled84 locationsNCT07218926
Recruiting
Not Applicable
Traction vs. No Traction in Colonic ESD
Gastrointestinal Neoplasm
Baylor College of Medicine150 enrolled2 locationsNCT06159634
Recruiting
Not Applicable
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Gastrointestinal Neoplasm
Baylor College of Medicine66 enrolled2 locationsNCT06134687
Recruiting
Not Applicable
Telephone Support in Advanced Gastrointestinal Cancer
Caregiver BurdenGastrointestinal Neoplasm Malignant
Indiana University488 enrolled4 locationsNCT06532877
Recruiting
Phase 1Phase 2
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Gastrointestinal Neoplasms
GlaxoSmithKline320 enrolled47 locationsNCT06885034
Recruiting
Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled30 locationsNCT05489237